Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT02594813

Bleeding Rate After EGD and Colonoscopy in Patients Who Continue to Take Antithrombotic Agents

Sponsor: Showa Inan General Hospital

View on ClinicalTrials.gov

Summary

The bleeding rate of both EGD (including biopsy) and colonoscopy (including biopsy, cold or hot snare polypectomy, or EMR) in patients who continue to take various antithrombotic drugs is studied prospectively. The immediate or delayed bleeding that requires hemostatic clipping or other endoscopic treatments is defined as the bleeding. Immediate bleeding requiring hemostatic clipping is defined as spurting or oozing which continued for more than 30 seconds. Delayed bleeding is defined as bleeding that requires the endoscopic treatment within 2 weeks after endoscopy. Prophylactic clipping is not performed after taking biopsy and doing polypectomy. Additionally, investigators evaluate the rate of injured submucosal arteries of the excised specimen when the bleeding occurs.

Key Details

Gender

All

Age Range

20 Years - 90 Years

Study Type

OBSERVATIONAL

Enrollment

10000

Start Date

2015-11

Completion Date

2026-12

Last Updated

2025-05-15

Healthy Volunteers

No

Interventions

PROCEDURE

Biopsy, cold or hot snare polypectomy, or EMR

Locations (1)

Showa Inan General Hospital

Komagane, Japan